lovastatin has been researched along with Cerebral Cholesterinosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batta, AK; Salen, G; Tint, GS | 1 |
| Dotti, MT; Federico, A; Lindenthal, B; Lütjohann, D; Simatupang, A; von Bergmann, K | 1 |
1 trial(s) available for lovastatin and Cerebral Cholesterinosis
| Article | Year |
|---|---|
Hydrophilic 7 beta-hydroxy bile acids, lovastatin, and cholestyramine are ineffective in the treatment of cerebrotendinous xanthomatosis.
Topics: Adult; Anticholesteremic Agents; Bile; Bile Acids and Salts; Case-Control Studies; Chenodeoxycholic Acid; Cholestanols; Cholesterol; Cholestyramine Resin; Cholic Acids; Homozygote; Humans; Lovastatin; Male; Middle Aged; Ursodeoxycholic Acid; Xanthomatosis, Cerebrotendinous | 2004 |
1 other study(ies) available for lovastatin and Cerebral Cholesterinosis
| Article | Year |
|---|---|
Urinary excretion of mevalonic acid as an indicator of cholesterol synthesis.
Topics: Adult; Aged; Anticholesteremic Agents; Cholesterol; Cholestyramine Resin; Circadian Rhythm; Female; Humans; Hypercholesterolemia; Lovastatin; Male; Mevalonic Acid; Middle Aged; Pravastatin; Reproducibility of Results; Simvastatin; Xanthomatosis, Cerebrotendinous | 1996 |